Search Results 321-330 of 11344 for Antifungal Resistance

  1. A Study To Compare The Effectiveness And Safety Of JCAR017 To Standard Of Care In Adult Subjects With High-risk, Transplant-eligible Relapsed Or Refractory Aggressive B-cell Non-Hodgkin Lymphomas - Mayo Clinic

    Subjects with uncontrolled systemic fungal, bacterial, viral or other infection (including tuberculosis) despite appropriate antibiotics or other treatment.

  2. Drugs and Supplements that Start with S - Mayo Clinic

    Scholl Tritin Antifungal Powder. Also known as. Tolnaftate (topical route). Scholl Tritin Antifungal Spray Powder. Also known as. Tolnaftate (topical route).

  3. Doxorubicin Hydrochloride, Vinblastine, Dacarbazine, Brentuximab Vedotin, And Nivolumab In Treating Patients With Stage I-II Hodgkin Lymphoma - Mayo Clinic

    History of progressive PML, known history of pancreatitis, active grade 3 or higher viral, bacterial or fungal infection ≤ 2 weeks prior to registration ...

  4. A Study To Assess Change In Disease Activity And Adverse Events Of Oral Upadacitinib In Adult And Adolescent Participants With Moderate To Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy - Mayo Clinic

    * History of active skin disease other than HS that could interfere with the assessment of HS, including skin infections (bacterial, fungal, or viral) ...

  5. Mayo Clinic

    Fuel groundbreaking medical research! ... Your donation powers the future of medicine and helps save lives. Give Today.

  6. A Study Of TAK-981 In Combination With Rituximab In Participants With Relapsed/Refractory (R/r) CD20-positive (CD20+) Non-Hodgkin Lymphoma (NHL) - Mayo Clinic

    ... fungal infections, severely immunocompromised state, severe non-compensated hypertension and congestive heart failure New York Heart Association Class III ...

  7. A Study To Compare Three Chemotherapy Regimens For The Treatment Of Patients With Newly- Diagnosed Mantle Cell Lymphoma - Mayo Clinic

    Known active bacterial, viral, fungal, mycobacterial, parasitic, or other infections at study enrollment (defined as exhibiting ongoing signs/symptoms ...

  8. Evaluation Of The Efficacy And Safety Of Sarilumab In Hospitalized Patients With COVID-19 (Enrollment By Invitation Only) - Mayo Clinic

    Patients with suspected or known active systemic bacterial or fungal infections. Patients who have received immunosuppressive antibody therapy within the ...

  9. General Internal Medicine - Clinical trials

    This is a pilot study to evaluate whether targeting inflammation will help reduce markers of insulin resistance inflammation, bone resorption and physical ...

  10. PoC Study To Evaluate The Efficacy And Safety Of Secukinumab 300 Mg In Patients With Lichen Planus - Mayo Clinic

    Diagnosis of active infectious diseases of the skin, scalp or mucosa (for example bacterial, viral or fungal infections of the mouth) that may interfere ...